Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Miraculins Inc

+ Add to Watchlist

MCUIF:US

Price not available for MCUIF:US

Snapshot for Miraculins Inc (MCUIF)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 0.0820 - 0.1080 1-Yr Rtn: -

Stock Chart for MCUIF

No chart data available.
  • MCUIF:US 0.0900
  • 1M
  • 1Y
0.0000
Interactive MCUIF Chart

Previous Close

Key Statistics for MCUIF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MCUIF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for MCUIF

Miraculins Inc. is a biotechnology company. The Company discovers and develops diagnostics and therapeutic targets for select cancers.

Harry J F BloomfieldInterim ChairmanChristopher J MoreauPresident/CEO
James F KinleyChief Financial Officer
More Company Profile & Key Executives for MCUIF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil